Company / R&D per Share
iSpecimen Inc. R&D per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.56
FY2024
5-year range
$0.10 / $3.56
FY2021-FY2024
Trend
+2059.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +2059% YoY in FY2024, a notable deviation from the 3-year average annual change of +684%.
Based on SEC 10-K filings.
3.56 in FY2024 with a 3-year CAGR of +118.7%.
Improved from $0.10 to $3.56 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +118.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, r&d per share increased 2059.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.90 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $3.56 | +2059.1% |
| FY2023 | $0.17 | +64.0% |
| FY2022 | $0.10 | -70.5% |
| FY2021 | $0.34 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026